Medindia

X

Sequenom to Webcast Analyst and Investor Briefing Presentation on September 24

Saturday, September 22, 2007 General News J E 4
Advertisement
SAN DIEGO, Sept. 21 Sequenom, Inc.(Nasdaq: SQNM) today announced that a live audio webcast and accompanyingslide presentation will be provided for its analyst and investor briefingevent "Sequenom Today and Tomorrow." Details of the event are as follows:

Sequenom is committed to providing the best genetic analysis products thattranslate genomic science into superior solutions for biomedical research,livestock and agricultural applications, molecular medicine, and non-invasiveprenatal testing. The Company's proprietary MassARRAY(R) system is a high-performance DNA analysis platform that efficiently and precisely measures theamount of genetic target material and variations therein. The system is ableto deliver reliable and specific data from complex biological samples and fromgenetic target material that is only available in trace amounts. The Companyhas exclusively licensed intellectual property rights for the development andcommercialization of non-invasive prenatal genetic tests for use with theMassARRAY system and other platforms.

Minimum Requirements to listen to broadcast:

The Windows Media Player software, downloadable free fromhttp://www.microsoft.com and at least a 56Kbps connection to the Internet. Ifyou experience problems listening to the webcast, send an E-mail to:webcast@multivu.com.(Logo: http://www.newscom.com/cgi-bin/prnh/20040415/SQNMLOGO) What: Sequenom Today and Tomorrow When: Monday, September 24, 2007 at 4:15 p.m. Eastern time Where: http://www.sequenom.com How: Live over the Internet -- Simply log on to the web at the address above. Contact: Lippert/Heilshorn & Associates Jody Cain (jcain@lhai.com) 310-691-7100

SOURCE Sequenom, Inc.
Advertisement


Advertisement

You May Also Like

Advertisement
View All

Post your Comments

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
User Avatar
* Your comment can be maximum of 2500 characters
I agree to the terms and conditions
s
Biodel Inc. Expands Ongoing Phase III VIAject(TM) ...
S
Recombinant Human Renin - Crystallographic Grade